Skip to main content

Advertisement

SpringerLink
Log in

Natural history of graves’ orbitopathy after treatment

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Intravenous glucocorticoids are used for Graves’ orbitopathy, alone or associated with/followed by additional treatments (orbital radiotherapy, orbital decompression, palpebral or eye surgery). However, the relation between associated/additional treatments and other variables with Graves’ orbitopathy outcome following intravenous glucocorticoids is not clear. Thus, the present study was conducted to investigate retrospectively the impact of associated/additional treatments and other variables on Graves’ orbitopathy outcome after intravenous glucocorticoids. We evaluated 226 untreated Graves’ orbitopathy patients. Following first observation, patients were given intravenous glucocorticoids and re-examined after a median of 46.5 months. The end-points were the relation between Graves’ orbitopathy outcome, outcome of NOSPECS score and of the single Graves’ orbitopathy features with several variables, including associated/additional treatments. All Graves’ orbitopathy features improved significantly after treatment. Overall, Graves’ orbitopathy improved in ~60 % of patients (responders), whereas it was stable or worsened in ~40 % of patients (non-responders). Time between first and last observation and clinical activity score at first observation correlated significantly with Graves’ orbitopathy outcome. The outcomes of NOSPECS, eyelid aperture, clinical activity score and diplopia correlated with time between the first and last observation. The NOSPECS outcome correlated with gender. The outcomes of proptosis, eyelid aperture and visual acuity correlated with orbital decompression. The outcome of diplopia correlated with orbital radiotherapy. Taking into account the limitations of retrospective investigations, our findings confirm that time (i.e. the natural history of Graves’ orbitopathy) is a key factor in determining the long-term outcome of Graves’ orbitopathy, radiotherapy is effective for diplopia, and orbital decompression is followed by an amelioration of several Graves’ orbitopathy features.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. L. Bartalena, L. Baldeschi, K. Boboridis, A. Eckstein, G.J. Kahaly, C. Marcocci, P. Perros, M. Salvi, W.M. Wiersinga; European Group on Graves’ Orbitopathy (EUGOGO), The 2016 European thyroid association/European group on Graves’ orbitopathy guidelines for the management of graves’ orbitopathy. Eur. Thyroid J. 5, 9–26 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. L. Bartalena, A. Pinchera, C. Marcocci, Management of Graves’ ophthalmopathy: reality and perspectives. Endocr. Rev. 212, 168–199 (2000)

    Google Scholar 

  3. C. Marcocci, M. Marinò, Treatment of mild, moderate-to-severe and very severe Graves’ orbitopathy. Best Pract. Res. Clin. Endocrinol. Metab. 26, 325–337 (2012)

    Article  PubMed  Google Scholar 

  4. C. Marcocci, A. Pinchera, M. Marinò, A treatment strategy for Graves’ orbitopathy. Nat. Clin. Pract. Endocrinol. Metab. 3, 430–436 (2007)

    Article  PubMed  Google Scholar 

  5. A.K. Eckstein, M. Plicht, H. Lax, M. Neuhäuser, K. Mann, S. Lederbogen, C. Heckmann, J. Esser, N.G. Morgenthaler, Thyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the disease. J. Clin. Endocrinol. Metab. 91, 3464–3470 (2006)

    Article  CAS  PubMed  Google Scholar 

  6. W.M. Wiersinga, Smoking and thyroid. Clin. Endocrinol. (Oxf) 79, 145–151 (2013)

    Article  CAS  Google Scholar 

  7. F. Menconi, M. Marinò, A. Pinchera, R. Rocchi, B. Mazzi, M. Nardi, L. Bartalena, C. Marcocci, Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves’ orbitopathy treated with intravenous glucocorticoids. J. Clin. Endocrinol. Metab. 92, 1653–1658 (2007)

    Article  CAS  PubMed  Google Scholar 

  8. M. Leo, C. Marcocci, A. Pinchera, M. Nardi, L. Megna, R. Rocchi, F. Latrofa, M.A. Altea, B. Mazzi, E. Sisti, M.A. Profilo, M. Marinò, Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial. J. Clin. Endocrinol. Metab. 97, E44–E48 (2012)

    Article  CAS  PubMed  Google Scholar 

  9. F. Menconi, M. Leo, P. Vitti, C. Marcocci, M. Marinò, Total thyroid ablation in Graves’ orbitopathy. J. Endocrinol. Invest. 38, 809–815 (2015)

    Article  CAS  PubMed  Google Scholar 

  10. G.B. Bartley, Rundle and his curve. Arch. Ophthalmol. 129, 356–358 (2011)

    Article  PubMed  Google Scholar 

  11. F. Menconi, M.A. Profilo, M. Leo, E. Sisti, M.A. Altea, R. Rocchi, F. Latrofa, M. Nardi, P. Vitti, C. Marcocci, M. Marinò, Spontaneous improvement of untreated mild Graves’ ophthalmopathy: Rundle’s curve revisited. Thyroid 24, 60–66 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. E. Sisti, F. Menconi, M. Leo, M.A. Profilo, T. Mautone, B. Mazzi, R. Rocchi, F. Latrofa, M. Nardi, P. Vitti, C. Marcocci, M. Marinò, Long-term outcome of Graves’ orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy. J. Endocrinol. Invest. 38, 661–668 (2015)

    Article  CAS  PubMed  Google Scholar 

  13. M. Leo, T. Mautone, I. Ionni, M.A. Profilo, E. Sabini, F. Menconi, B. Mazzi, R. Rocchi, F. Latrofa, M. Nardi, P. Vitti, C. Marcocci, M. Marinò, Variables affecting the long term outcome of Graves’ orbitopathy following high dose intravenous glucocorticoid pulse therapy in patients not treated with orbital radiotherapy. Endoc. Pract. [in press]

  14. L. Bartalena, C. Marcocci, L. Chiovato, M. Laddaga, G. Lepri, D. Andreani, G. Cavallacci, L. Baschieri, A. Pinchera, Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophthalmopathy: comparison with systemic corticosteroids alone. J. Clin. Endocrinol. Metab. 56, 1139–1144 (1983)

    Article  CAS  PubMed  Google Scholar 

  15. C. Marcocci, L. Bartalena, F. Bogazzi, G. Bruno-Bossio, A. Lepri, A. Pinchera, Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves’ ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. J. Endocrinol. Invest. 14, 853–860 (1991)

    Article  CAS  PubMed  Google Scholar 

  16. M.P. Mourits, M.F. Prummel, W.M. Wiersinga, L. Koornneef, Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin. Endocrinol. (Oxf) 47, 9–14 (1997)

    Article  CAS  Google Scholar 

  17. L. Bartalena, L. Baldeschi, A.J. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M.P. Mourits, P. Perros, K. Boboridis, A. Boschi, N. Currò, C. Daumerie, G.J. Kahaly, G. Krassas, C.M. Lane, J.H. Lazarus, M. Marinò, M. Nardi, C. Neoh, J. Orgiazzi, S. Pearce, A. Pinchera, S. Pitz, M. Salvi, P. Sivelli, M. Stahl, G. von Arx, W.M. Wiersinga, Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid 18, 333–346 (2008)

    Article  PubMed  Google Scholar 

  18. W.M. Wiersinga, P. Perros, G.J. Kahaly, M.P. Mourits, L. Baldeschi, K. Boboridis, A. Boschi, A.J. Dickinson, P. Kendall-Taylor, G.E. Krassas, C.M. Lane, J.H. Lazarus, C. Marcocci, M. Marino, M. Nardi, C. Neoh, J. Orgiazzi, A. Pinchera, S. Pitz, M.F. Prummel, M.S. Sartini, M. Stahl, G. von Arx, Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur. J. Endocrinol. 155, 387–389 (2006)

    Article  CAS  PubMed  Google Scholar 

  19. M.A. Profilo, E. Sisti, C. Marcocci, P. Vitti, A. Pinchera, M. Nardi, R. Rocchi, F. Latrofa, F. Menconi, M.A. Altea, M. Leo, T. Rago, M. Marinò, Thyroid volume and severity of Graves’ orbitopathy. J. Endocrinol. Invest. 23, 97–102 (2013)

  20. S.C. Werner, Modification of the classification of the eye changes of Graves’ disease: recommendations of the Ad Hoc committee of the American thyroid association. J. Clin. Endocrinol. Metab. 44, 203–204 (1977)

    Article  CAS  PubMed  Google Scholar 

  21. S. Zang, K.A. Ponto, G.J. Kahaly, Clinical review: Intravenous glucocorticoids for Graves’ orbitopathy: efficacy and morbidity. J. Clin. Endocrinol. Metab. 96, 320–332 (2011)

    Article  CAS  PubMed  Google Scholar 

  22. R. Rocchi, R. Lenzi, M. Marinò, F. Latrofa, M. Nardi, P. Piaggi, B. Mazzi, M.A. Altea, A. Pinchera, P. Vitti, C. Marcocci, S. Sellari-Franceschini, Rehabilitative orbital decompression for Graves’ orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients’ satisfaction. Thyroid 22, 1170–1175 (2012)

    Article  PubMed  Google Scholar 

  23. C. Marcocci, M. Marinò, R. Rocchi, F. Menconi, E. Morabito, A. Pinchera, Novel aspects of immunosuppressive and radiotherapy management of Graves’ ophthalmopathy. J. Endocrinol. Invest. 27, 272–280 (2004)

    Article  CAS  PubMed  Google Scholar 

  24. M. Moleti, M.A. Violi, D. Montanini, C. Trombetta, B. Di Bella, G. Sturniolo, S. Presti, A. Alibrandi, A. Campennì, S. Baldari, F. Trimarchi, F. Vermiglio, Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe graves’ orbitopathy (GO): a prospective, randomized, single-blind clinical trial. J. Clin. Endocrinol. Metab. 99, 1783–1789 (2014)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, Endocrinology Units, University of Pisa and University Hospital of Pisa, Pisa, Italy

    Francesca Menconi, Marenza Leo, Elena Sabini, Paolo Vitti, Claudio Marcocci & Michele Marinò

  2. Department of Surgical, Medical and Molecular Pathology, Ophthalmopathy Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy

    Teresa Mautone & Marco Nardi

  3. Radiotherapy Unit, University Hospital of Pisa, Pisa, Italy

    Aldo Sainato

  4. Department of Surgical, Medical and Molecular Pathology, ENT Unit I, University of Pisa and University Hospital of Pisa, Pisa, Italy

    Stefano Sellari-Franceschini

Authors
  1. Francesca Menconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marenza Leo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Sabini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Teresa Mautone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marco Nardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aldo Sainato
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stefano Sellari-Franceschini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paolo Vitti
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Claudio Marcocci
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michele Marinò
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michele Marinò.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Menconi, F., Leo, M., Sabini, E. et al. Natural history of graves’ orbitopathy after treatment. Endocrine 57, 226–233 (2017). https://doi.org/10.1007/s12020-016-1136-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1136-x

Keywords

Search

Navigation